ResearcherKurume UniversityNo recent work listed
Jun Akiba
Matched on ORCID iD 0000-0003-2657-8604; OpenAlex author ID A5024527863. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper
Papers 7
- KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer. Last author DOI 10.21873/anticanres.16434↗
- Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma. First author DOI 10.21873/anticanres.15913↗
- A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy. Co-author DOI 10.1038/s41598-021-87748-0↗
- Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer. Co-author PMID 33790164↗
- A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection. Co-author DOI 10.4103/eus.eus_58_17↗
- ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of th… Co-author DOI 10.1186/s12943-016-0516-4↗
- Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. Co-author DOI 10.1007/s00795-010-0511-6↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshinobu Okabe · 6 shared papers, 2011–2023 · strength 0.58
- Paper KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer. DOI 10.21873/anticanres.16434↗
- Paper Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15913↗
- Paper A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy. DOI 10.1038/s41598-021-87748-0↗
- Yoshiki Naito · 6 shared papers, 2011–2023 · strength 0.58
- Paper KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer. DOI 10.21873/anticanres.16434↗
- Paper Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15913↗
- Paper A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy. DOI 10.1038/s41598-021-87748-0↗
- Hirohisa Yano · 5 shared papers, 2011–2022 · strength 0.40
- Paper Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma. DOI 10.21873/anticanres.15913↗
- Paper Neoadjuvant Hyperthermia and Chemoradiotherapy for Borderline Resectable Pancreatic Cancer. PMID 33790164↗
- Paper A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy. DOI 10.1038/s41598-021-87748-0↗
- Yorihiko Takase · 1 shared paper, 2023 · strength 0.20
- Hiroto Ishikawa · 2 shared papers, 2018–2021 · strength 0.19
- Yusuke Ishida · 3 shared papers, 2011–2018 · strength 0.15
- Paper A case of gastric wall implantation caused by EUS-FNA 22 months after pancreatic cancer resection. DOI 10.4103/eus.eus_58_17↗
- Paper ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the m… DOI 10.1186/s12943-016-0516-4↗
- Paper Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements a… DOI 10.1007/s00795-010-0511-6↗
- Toru Hisaka · 1 shared paper, 2022 · strength 0.13
- Aoi Sukeda · 1 shared paper, 2021 · strength 0.09
- Yoshihiro Hamada · 1 shared paper, 2021 · strength 0.09
- Kenji Notohara · 1 shared paper, 2021 · strength 0.09
- Yoshinao Oda · 1 shared paper, 2021 · strength 0.09
- Noriyoshi Fukushima · 1 shared paper, 2021 · strength 0.09
- Motohiro Kojima · 1 shared paper, 2021 · strength 0.09
- Kenichi Hirabayashi · 1 shared paper, 2021 · strength 0.09
- Michiyo Higashi · 1 shared paper, 2021 · strength 0.09
- Yuko Omori · 1 shared paper, 2021 · strength 0.09
- Tomoko Norose · 1 shared paper, 2021 · strength 0.09
- Toru Furukawa · 1 shared paper, 2021 · strength 0.09
- Tomoyuki Ushijima · 1 shared paper, 2018 · strength 0.08
- Takuji Torimura · 1 shared paper, 2018 · strength 0.08
- Yuhei Kitasato · 1 shared paper, 2016 · strength 0.05
- Hiroyuki Horiuchi · 1 shared paper, 2016 · strength 0.05
- Hiroto S. Fukushima · 1 shared paper, 2016 · strength 0.05
- Manabu Nakashima · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.